
    
      This study is a Phase I, FIH, randomized, single-blinded (study center staff remain blinded
      during the dosing phase of the study), placebo-controlled, single ascending dose, sequential
      dose group study in healthy male subjects and/or female subjects of non-childbearing
      potential at a single study center to assess AZD5634 following inhaled and intravenous dose
      administration
    
  